---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-018260"
form_type: "8-K"
ticker: "MBOT"
cik: "0000883975"
company_name: "Microbot Medical Inc."
filed_at: "2025-10-16T23:59:59+00:00"
generated_at: "2026-05-17T03:39:12.080578+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Microbot Medical to debut LIBERTY System at CIO meeting; hires commercial team

## Summary
- First commercial exhibition of LIBERTY Endovascular Robotic System at CIO symposium in Miami, Oct 17-19, 2025.
- Completed hiring of commercial leadership: Justin Bourne (Regional Sales Dir), Dani Kulp (Sales Training Dir), Xiomara Ortiz (Marketing Comm Mgr).
- Limited market launch of LIBERTY System remains on track for Q4 2025.
- FDA 510(k) clearance received in early September 2025.

## SEC filing metadata
- accession: 0001493152-25-018260
- form_type: 8-K
- ticker: MBOT
- cik: 0000883975
- company_name: Microbot Medical Inc.
- filed_at: 2025-10-16T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/883975/000149315225018260/0001493152-25-018260-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/883975/000149315225018260/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-018260
- JSON: https://secwatch.observer/filing/0001493152-25-018260.json
- Plain text: https://secwatch.observer/filing/0001493152-25-018260.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.